|
Real-time Estimate
Cboe BZX
12:39:23 2026-11-12 EST
|
5-day change | 1st Jan Change | ||
| 82.84 USD | +0.33% |
|
+1.19% | -33.96% |
| 11-11 | Zoetis Wins License for 75-Day Canine Allergy Treatment | MT |
| 11-11 | Zoetis Inc. Receives USDA License For Cytopoint Plus For Treatment Of Allergic Dermatitis In Dogs | CI |
| Market Cap | 33.55B 30.34B 28B 25.35B 47.83B 3,154B 49.27B 336B 134B 1,686B 126B 123B 5,367B | P/E 2026 * |
14.5x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 40.2B 36.35B 33.56B 30.37B 57.32B 3,779B 59.03B 403B 160B 2,020B 151B 148B 6,431B | EV / Sales 2026 * |
4.33x | EV / Sales 2027 * | 4.26x |
| Free-Float |
80.99% | Yield 2026 * |
2.57% | Yield 2027 * | 2.72% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ZTS | Delayed | |
| ZTS | Real-time | ||
| ZOE | Real-time | ||
| ZTS * | End-of-day quote | ||
| 0M3Q | Delayed | ||
| ZOE | Delayed | ||
| ZOE | Delayed | ||
| ZOE | Real-time | ||
| ZOE | Delayed | ||
| 1ZTS | End-of-day quote | ||
| ZOTS | End-of-day quote | ||
| ZTS | Delayed | ||
| ZTS | Delayed | ||
| ZTSUS | End-of-day quote | ||
| 0M3Q | Real-time | ||
| Real-time |
Last Transcript: Zoetis Inc.
| 1 day | +0.30% | ||
| 1 week | +1.19% | ||
| Current month | +4.23% | ||
| 1 month | +9.83% | ||
| 3 months | +12.99% | ||
| 6 months | +7.99% | ||
| Current year | -33.96% |
| 1 week | 78.63 | 83.84 | |
| 1 month | 74.25 | 89.29 | |
| Current year | 68.77 | 132.49 | |
| 1 year | 68.77 | 132.49 | |
| 3 years | 68.77 | 201.92 | |
| 5 years | 68.77 | 249.27 | |
| 10 years | 48.24 | 249.27 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kristin Peck
CEO | Chief Executive Officer | 54 | 2019-12-31 |
James Saccaro
DFI | Director of Finance/CFO | 53 | 2026-08-16 |
Kevin Esch
CTO | Chief Tech/Sci/R&D Officer | 49 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank D'Amelio
BRD | Director/Board Member | 68 | 2012-06-30 |
Gregory Norden
BRD | Director/Board Member | 68 | 2012-12-31 |
| Chairman | 73 | 2013-06-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/30/26 | Free | Director | 6 | 0.0000% | ||
| 10/9/26 | Free | Executive Vice President | 321 | 0.0001% | - | |
| 10/9/26 | Free | Executive/Senior Manager | 278 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.33% | +1.19% | -31.47% | -50.78% | 33.55B | ||
| +0.76% | +6.27% | +42.49% | +136.69% | 1,280B | ||
| +1.72% | +4.92% | +46.99% | +93.54% | 675B | ||
| +0.58% | +3.04% | +27.34% | +114.22% | 521B | ||
| +1.14% | +3.78% | +39.98% | +70.26% | 386B | ||
| +1.29% | +1.35% | +62.85% | +45.34% | 363B | ||
| +1.11% | +0.07% | +28.19% | +58.61% | 301B | ||
| +0.24% | -0.80% | +3.05% | +35.93% | 286B | ||
| +0.64% | +2.47% | +40.26% | +76.85% | 253B | ||
| +0.45% | +1.93% | +38.42% | +127.96% | 211B | ||
| Average | +0.84% | -1.21% | +29.81% | +70.86% | 431B | |
| Weighted average by Cap. | +0.96% | +0.14% | +38.33% | +96.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.29B 8.4B 7.75B 7.02B 13.24B 873B 13.64B 93.05B 36.98B 467B 34.86B 34.11B 1,486B | 9.34B 8.44B 7.79B 7.06B 13.31B 878B 13.71B 93.56B 37.18B 469B 35.05B 34.3B 1,494B |
| Net income | 2.4B 2.17B 2.01B 1.82B 3.43B 226B 3.53B 24.08B 9.57B 121B 9.02B 8.83B 384B | 2.41B 2.18B 2.01B 1.82B 3.44B 227B 3.54B 24.16B 9.6B 121B 9.05B 8.86B 386B |
| Net Debt | 6.65B 6.01B 5.55B 5.02B 9.48B 625B 9.77B 66.63B 26.48B 334B 24.96B 24.43B 1,064B | 6.25B 5.65B 5.22B 4.72B 8.92B 588B 9.18B 62.65B 24.9B 314B 23.47B 22.97B 1,000B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-12 | US$83.15 | +0.70% | 889,023 |
| 26-11-11 | US$82.57 | +0.13% | 4,450,294 |
| 26-11-10 | US$82.46 | +0.17% | 4,894,311 |
| 26-11-09 | US$82.32 | +3.68% | 6,205,132 |
| 26-11-06 | US$79.40 | -3.30% | 6,024,575 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ZTS Stock
Select your edition
All financial news and data tailored to specific country editions


















